TCL Archive The shadow of Iressa lingered over the FDA Oncologic Drugs Advisory Committee as the panel voted down Genasense (Genta Inc.) and RSR13 (Allos Therapeutics Inc.) at its May 3 meeting. If anyone thought the bar had been lowered for drug approvals, they were mistaken. May 7, 2004
TCL Archive ACC Will Develop Standards, Patient Management Guidelines To Upgrade Community Cancer Programs March 23, 1984
TCL Archive Johnson, Katterhagen Applaud CCOP RFA But With It Had Money For More Cancer Control July 30, 1982
TCL Archive In Brief: Judge Rules FDA Modernization Act Violates First Amendment Over Publications Policy August 6, 1999
